Clinical and molecular delineation of the 17q21.31 microdeletion syndrome
- 1 November 2008
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 45 (11), 710-720
- https://doi.org/10.1136/jmg.2008.058701
Abstract
Background: The chromosome 17q21.31 microdeletion syndrome is a novel genomic disorder that has originally been identified using high resolution genome analyses in patients with unexplained mental retardation. Aim: We report the molecular and/or clinical characterisation of 22 individuals with the 17q21.31 microdeletion syndrome. Results: We estimate the prevalence of the syndrome to be 1 in 16 000 and show that it is highly underdiagnosed. Extensive clinical examination reveals that developmental delay, hypotonia, facial dysmorphisms including a long face, a tubular or pear-shaped nose and a bulbous nasal tip, and a friendly/amiable behaviour are the most characteristic features. Other clinically important features include epilepsy, heart defects and kidney/urologic anomalies. Using high resolution oligonucleotide arrays we narrow the 17q21.31 critical region to a 424 kb genomic segment (chr17: 41046729–41470954, hg17) encompassing at least six genes, among which is the gene encoding microtubule associated protein tau (MAPT). Mutation screening of MAPT in 122 individuals with a phenotype suggestive of 17q21.31 deletion carriers, but who do not carry the recurrent deletion, failed to identify any disease associated variants. In five deletion carriers we identify a −5). Conclusion: Our data establish the 17q21.31 microdeletion syndrome as a clinically and molecularly well recognisable genomic disorder.Keywords
This publication has 41 references indexed in Scilit:
- Two-color multiplex ligation-dependent probe amplification: Detecting genomic rearrangements in hereditary multiple exostosesHuman Mutation, 2004
- Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic featuresJournal of Medical Genetics, 2004
- Mutations in RAI1 associated with Smith–Magenis syndromeNature Genetics, 2003
- Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplificationNucleic Acids Research, 2002
- Genome architecture, rearrangements and genomic disordersTrends in Genetics, 2002
- The epidemiology of mental retardation: Challenges and opportunities in the new millenniumMental Retardation and Developmental Disabilities Research Reviews, 2002
- Pick's disease is associated with mutations in the tau geneAnnals of Neurology, 2000
- TauGene Mutation G389R Causes a Tauopathy with Abundant Pick Body-like Inclusions and Axonal DepositsJournal of Neuropathology and Experimental Neurology, 1999
- The prevalence of mental retardation: a critical review of recent literatureDevelopmental Medicine and Child Neurology, 1997
- UBE3A/E6-AP mutations cause Angelman syndromeNature Genetics, 1997